1. Home
  2. EVO vs ADEA Comparison

EVO vs ADEA Comparison

Compare EVO & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • ADEA
  • Stock Information
  • Founded
  • EVO 1993
  • ADEA 1990
  • Country
  • EVO Germany
  • ADEA United States
  • Employees
  • EVO N/A
  • ADEA N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • ADEA Computer Software: Prepackaged Software
  • Sector
  • EVO Health Care
  • ADEA Technology
  • Exchange
  • EVO Nasdaq
  • ADEA Nasdaq
  • Market Cap
  • EVO 1.4B
  • ADEA 1.5B
  • IPO Year
  • EVO 2021
  • ADEA N/A
  • Fundamental
  • Price
  • EVO $3.97
  • ADEA $12.84
  • Analyst Decision
  • EVO Buy
  • ADEA Strong Buy
  • Analyst Count
  • EVO 2
  • ADEA 3
  • Target Price
  • EVO $5.90
  • ADEA $17.33
  • AVG Volume (30 Days)
  • EVO 201.5K
  • ADEA 495.4K
  • Earning Date
  • EVO 05-06-2025
  • ADEA 05-05-2025
  • Dividend Yield
  • EVO N/A
  • ADEA 1.56%
  • EPS Growth
  • EVO N/A
  • ADEA 89.09
  • EPS
  • EVO N/A
  • ADEA 0.66
  • Revenue
  • EVO $851,944,444.00
  • ADEA $380,289,000.00
  • Revenue This Year
  • EVO $10.08
  • ADEA $10.68
  • Revenue Next Year
  • EVO $10.99
  • ADEA $4.16
  • P/E Ratio
  • EVO N/A
  • ADEA $19.46
  • Revenue Growth
  • EVO 1.50
  • ADEA 7.16
  • 52 Week Low
  • EVO $2.84
  • ADEA $9.68
  • 52 Week High
  • EVO $5.64
  • ADEA $17.46
  • Technical
  • Relative Strength Index (RSI)
  • EVO 48.96
  • ADEA 46.74
  • Support Level
  • EVO $3.78
  • ADEA $12.62
  • Resistance Level
  • EVO $4.80
  • ADEA $13.02
  • Average True Range (ATR)
  • EVO 0.14
  • ADEA 0.29
  • MACD
  • EVO -0.04
  • ADEA -0.08
  • Stochastic Oscillator
  • EVO 18.63
  • ADEA 14.62

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About ADEA Adeia Inc.

Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, it primarily license innovations to leading companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.

Share on Social Networks: